Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine Injection in Hemodialysis Patients
NCT00173706Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levocarnitine in carnitine deficiency, sponsored by National Taiwan University Hospital. Primary endpoints: Weakness, Improvement of hypotension and hematology profile and 2 more. Status: unknown.
02
Drugs
levocarnitine
03
Conditions
carnitine deficiency
Beyond the preview
Go deeper on NCT00173706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00173706.